1-3 of 3
Michael Green, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I-II Study of the Combination of Bendamustine and Pomalidomide with Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma.

Cristina Gasparetto, MD, Michael Green, MD, Anandgopal Srinivasan, MDcal Student, Yubin Kang, MD, David A. Rizzieri, MD, Carlos Decastro, MD, Louis F. Diehl, MD, Anne Beaven, MD, Zighuo Li, PhD, Arati V. Rao, MD, Anderson Garrett, Sascha Tuchman, MD, Gwynn D. Long, MD
Journal: Blood
Blood (2015) 126 (23): 1857.
https://doi.org/10.1182/blood.V126.23.1857.1857
Published: 2015
Journal Articles

Targeting the Human Notch 2-BCR Axis: A Driver of B-Cell Hyper-Responsiveness in Active Chronic Graft-Versus Host Disease (cGVHD)

Jonathan C. Poe, PhD, Wei Jia, MD, Zhiguo Li, PhD, Frances T. Hakim, PhD, Steven Z. Pavletic, MD, Jeremy J. Rose, BA, David A. Rizzieri, MD, Yiping Yang, MD PhD, Benny J. Chen, MD, Michael Green, MD, Sarah Anand, MD, Christian W. Siebel, PhD, Ivan Maillard, MD PhD, Nelson J. Chao, MD, Stefanie Sarantopoulos, MD PhD
Journal: Blood
Blood (2015) 126 (23): 145.
https://doi.org/10.1182/blood.V126.23.145.145
Published: 2015
Journal Articles

Anti-CD20 Monoclonal Antibody (rituximab) for Refractory PTLD after Pediatric Solid Organ Transplantation: Multicenter Experience from a Registry and from a Prospective Clinical Trial.

Steven Webber, MBChB, William Harmon, MD, Albert Faro, MD, Michael Green, MD, Minnie Sarwal, MD, Robert Hayashi, MD, Charles Canter, MD, Dawn Thomas, RN, Ron Jaffe, MD, Richard Fine, MD
Journal: Blood
Blood (2004) 104 (11): 746.
https://doi.org/10.1182/blood.V104.11.746.746
Published: 2004